• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎所致急性呼吸窘迫综合征患者血管外肺水及肺血管通透性与呼吸力学的关系

Relationship of Extravascular Lung Water and Pulmonary Vascular Permeability to Respiratory Mechanics in Patients with COVID-19-Induced ARDS.

作者信息

Lardet Florian, Monnet Xavier, Teboul Jean-Louis, Shi Rui, Lai Christopher, Fossé Quentin, Moretto Francesca, Gobé Thibaut, Jelinski Ludwik, Combet Margot, Pavot Arthur, Guérin Laurent, Pham Tài

机构信息

Service de Médecine Intensive-Réanimation, Hôpital de Bicêtre, DMU CORREVE, FHU SEPSIS, Groupe de Recherche CARMAS, Hôpitaux Universitaires Paris-Saclay, AP-HP, 94270 Le Kremlin-Bicêtre, France.

Département d'Anesthésie-Réanimation et Médecine Périopératoire, Hôpital Tenon, AP-HP, Sorbonne Université, 75020 Paris, France.

出版信息

J Clin Med. 2023 Mar 3;12(5):2028. doi: 10.3390/jcm12052028.

DOI:10.3390/jcm12052028
PMID:36902815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10004335/
Abstract

During acute respiratory distress syndrome (ARDS), the increase in pulmonary vascular permeability and lung water induced by pulmonary inflammation may be related to altered lung compliance. A better understanding of the interactions between respiratory mechanics variables and lung water or capillary permeability would allow a more personalized monitoring and adaptation of therapies for patients with ARDS. Therefore, our main objective was to investigate the relationship between extravascular lung water (EVLW) and/or pulmonary vascular permeability index (PVPI) and respiratory mechanic variables in patients with COVID-19-induced ARDS. This is a retrospective observational study from prospectively collected data in a cohort of 107 critically ill patients with COVID-19-induced ARDS from March 2020 to May 2021. We analyzed relationships between variables using repeated measurements correlations. We found no clinically relevant correlations between EVLW and the respiratory mechanics variables (driving pressure (correlation coefficient [CI 95%]: 0.017 [-0.064; 0.098]), plateau pressure (0.123 [0.043; 0.202]), respiratory system compliance (-0.003 [-0.084; 0.079]) or positive end-expiratory pressure (0.203 [0.126; 0.278])). Similarly, there were no relevant correlations between PVPI and these same respiratory mechanics variables (0.051 [-0.131; 0.035], 0.059 [-0.022; 0.140], 0.072 [-0.090; 0.153] and 0.22 [0.141; 0.293], respectively). In a cohort of patients with COVID-19-induced ARDS, EVLW and PVPI values are independent from respiratory system compliance and driving pressure. Optimal monitoring of these patients should combine both respiratory and TPTD variables.

摘要

在急性呼吸窘迫综合征(ARDS)期间,肺部炎症引起的肺血管通透性增加和肺水增多可能与肺顺应性改变有关。更好地理解呼吸力学变量与肺水或毛细血管通透性之间的相互作用,将有助于对ARDS患者进行更个性化的监测和调整治疗方案。因此,我们的主要目的是研究新型冠状病毒肺炎(COVID-19)所致ARDS患者血管外肺水(EVLW)和/或肺血管通透性指数(PVPI)与呼吸力学变量之间的关系。这是一项回顾性观察研究,数据前瞻性收集自2020年3月至2021年5月的107例COVID-19所致ARDS重症患者队列。我们使用重复测量相关性分析变量之间的关系。我们发现EVLW与呼吸力学变量(驱动压(相关系数[95%置信区间]:0.017[-0.064;0.098])、平台压(0.123[0.043;0.202])、呼吸系统顺应性(-0.003[-0.084;0.079])或呼气末正压(0.203[0.126;0.278]))之间无临床相关相关性。同样,PVPI与这些相同的呼吸力学变量之间也无相关相关性(分别为0.051[-0.131;0.035]、0.059[-0.022;0.140]、0.072[-0.090;0.153]和0.22[0.141;0.293])。在COVID-19所致ARDS患者队列中,EVLW和PVPI值与呼吸系统顺应性和驱动压无关。对这些患者的最佳监测应同时结合呼吸和脉搏指示连续心输出量(TPTD)变量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/10004335/d92e43dd3782/jcm-12-02028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/10004335/5df2d07816c0/jcm-12-02028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/10004335/59611a769cfc/jcm-12-02028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/10004335/d92e43dd3782/jcm-12-02028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/10004335/5df2d07816c0/jcm-12-02028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/10004335/59611a769cfc/jcm-12-02028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4810/10004335/d92e43dd3782/jcm-12-02028-g003.jpg

相似文献

1
Relationship of Extravascular Lung Water and Pulmonary Vascular Permeability to Respiratory Mechanics in Patients with COVID-19-Induced ARDS.新型冠状病毒肺炎所致急性呼吸窘迫综合征患者血管外肺水及肺血管通透性与呼吸力学的关系
J Clin Med. 2023 Mar 3;12(5):2028. doi: 10.3390/jcm12052028.
2
COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study.COVID-19 相关急性呼吸窘迫综合征(ARDS)的血管外肺水较非 COVID-19 相关 ARDS 更高:PiCCOVID 研究。
Crit Care. 2021 Jun 1;25(1):186. doi: 10.1186/s13054-021-03594-6.
3
Extravascular lung water measurements in acute respiratory distress syndrome: why, how, and when?急性呼吸窘迫综合征的血管外肺水测量:为何、如何以及何时?
Curr Opin Crit Care. 2018 Jun;24(3):209-215. doi: 10.1097/MCC.0000000000000503.
4
Extravascular lung water in critical care: recent advances and clinical applications.重症监护中的血管外肺水:最新进展与临床应用。
Ann Intensive Care. 2015 Dec;5(1):38. doi: 10.1186/s13613-015-0081-9. Epub 2015 Nov 6.
5
The influence of sex, age, and body height on the pulmonary vascular permeability index - a prospective observational study.性别、年龄和身高对肺血管通透性指数的影响——一项前瞻性观察研究。
Sci Rep. 2024 Sep 23;14(1):22001. doi: 10.1038/s41598-024-72967-y.
6
Assessing pulmonary permeability by transpulmonary thermodilution allows differentiation of hydrostatic pulmonary edema from ALI/ARDS.通过经肺热稀释法评估肺通透性可区分静水压性肺水肿与急性肺损伤/急性呼吸窘迫综合征。
Intensive Care Med. 2007 Mar;33(3):448-53. doi: 10.1007/s00134-006-0498-6. Epub 2007 Jan 13.
7
The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/acute respiratory distress syndrome.血管外肺水和肺血管通透性指数在诊断和鉴别肺水肿中的临床应用:一项关于急性肺损伤/急性呼吸窘迫综合征定量鉴别诊断定义的前瞻性多中心研究。
Crit Care. 2012 Dec 11;16(6):R232. doi: 10.1186/cc11898.
8
Elevated Extravascular Lung Water Index (ELWI) as a Predictor of Failure of Continuous Positive Airway Pressure Via Helmet (Helmet-CPAP) in Patients With Acute Respiratory Failure After Major Surgery.体外肺水指数(ELWI)升高可预测大手术后急性呼吸衰竭患者经头盔行持续气道正压通气(Helmet-CPAP)失败。
Arch Bronconeumol. 2015 Nov;51(11):558-63. doi: 10.1016/j.arbres.2015.01.012. Epub 2015 Apr 20.
9
Diagnostic value of transpulmonary thermodilution measurements for acute respiratory distress syndrome in a pig model of septic shock.经肺热稀释测量对感染性休克猪模型急性呼吸窘迫综合征的诊断价值。
J Transl Med. 2022 Dec 23;20(1):617. doi: 10.1186/s12967-022-03793-x.
10
Relationship between extravascular lung water and severity categories of acute respiratory distress syndrome by the Berlin definition.根据柏林定义,血管外肺水与急性呼吸窘迫综合征严重程度分类之间的关系。
Crit Care. 2013 Jun 20;17(4):R132. doi: 10.1186/cc12811.

引用本文的文献

1
The influence of sex, age, and body height on the pulmonary vascular permeability index - a prospective observational study.性别、年龄和身高对肺血管通透性指数的影响——一项前瞻性观察研究。
Sci Rep. 2024 Sep 23;14(1):22001. doi: 10.1038/s41598-024-72967-y.

本文引用的文献

1
Extravascular lung water levels are associated with mortality: a systematic review and meta-analysis.血管外肺水水平与死亡率相关:系统评价和荟萃分析。
Crit Care. 2022 Jul 6;26(1):202. doi: 10.1186/s13054-022-04061-6.
2
COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study.COVID-19 相关急性呼吸窘迫综合征(ARDS)的血管外肺水较非 COVID-19 相关 ARDS 更高:PiCCOVID 研究。
Crit Care. 2021 Jun 1;25(1):186. doi: 10.1186/s13054-021-03594-6.
3
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
托珠单抗治疗重症 COVID-19 肺炎住院患者。
N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.
4
COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-A systematic review and meta-analysis.COVID-19 重症监护室和机械通气患者的特征和结局:一项系统评价和荟萃分析。
PLoS One. 2021 Feb 11;16(2):e0246318. doi: 10.1371/journal.pone.0246318. eCollection 2021.
5
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.4244 例危重症 COVID-19 成年患者的临床特征和第 90 天结局:一项前瞻性队列研究。
Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.
6
Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study.COVID-19 和典型 ARDS 的生理学和定量 CT 扫描特征:一项匹配队列研究。
Intensive Care Med. 2020 Dec;46(12):2187-2196. doi: 10.1007/s00134-020-06281-2. Epub 2020 Oct 21.
7
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
8
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
9
Esophageal Manometry.食管测压法。
Respir Care. 2020 Jun;65(6):772-792. doi: 10.4187/respcare.07425.
10
Cumulative fluid balance predicts mortality and increases time on mechanical ventilation in ARDS patients: An observational cohort study.累积液体平衡预测 ARDS 患者的死亡率和机械通气时间:一项观察性队列研究。
PLoS One. 2019 Oct 30;14(10):e0224563. doi: 10.1371/journal.pone.0224563. eCollection 2019.